Scopus BioPharma Inc. (SCPS) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Scopus BioPharma Inc. (SCPS) Bundle
Streamline your analysis and improve precision with our (SCPS) DCF Calculator! Equipped with up-to-date Scopus BioPharma Inc. data and customizable assumptions, this tool empowers you to forecast, evaluate, and value (SCPS) just like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2018 |
AY2 2019 |
AY3 2020 |
AY4 2021 |
AY5 2022 |
FY1 2023 |
FY2 2024 |
FY3 2025 |
FY4 2026 |
FY5 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -.7 | -2.7 | -10.2 | -27.6 | -11.7 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -.8 | -2.7 | -10.2 | -27.6 | -11.7 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | .0 | .0 | 1.8 | 7.9 | .1 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .7 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0.89672 | 0.89672 | 0.89672 | 0.89672 | 0.89672 | 0.89672 | 0.89672 | 0.89672 | 0.89672 | 0.89672 |
| EBITAT | -.8 | -2.7 | -10.8 | -28.4 | -11.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -.7 | -3.4 | -10.1 | -28.4 | -11.6 | .0 | .0 | .0 | .0 | .0 |
| WACC, % | 186.94 | 186.94 | 186.94 | 186.94 | 186.94 | 186.94 | 186.94 | 186.94 | 186.94 | 186.94 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | 0 | |||||||||
| Diluted Shares Outstanding, MM | 21 | |||||||||
| Equity Value Per Share | 0.01 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Scopus BioPharma Inc.’s (SCPS) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model designed to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical data and future forecasts for Scopus BioPharma Inc. (SCPS).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic refresh of DCF, Net Present Value (NPV), and cash flow analysis.
- User-Friendly Dashboard: Clear and informative charts and summaries to help visualize your valuation outcomes.
- Designed for All Skill Levels: An intuitive layout tailored for investors, CFOs, and consultants alike.
How It Works
- Download: Obtain the pre-built Excel file featuring Scopus BioPharma Inc.'s (SCPS) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and instantly compare results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose This Calculator for Scopus BioPharma Inc. (SCPS)?
- Designed for Industry Experts: A sophisticated tool tailored for biopharma analysts, investors, and strategic planners.
- Comprehensive Data: Scopus BioPharma’s historical and projected financials are preloaded for reliable analysis.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Step-by-step guidance ensures a seamless experience throughout the calculation process.
Who Should Use Scopus BioPharma Inc. (SCPS)?
- Investors: Gain insights into innovative biopharmaceutical solutions backed by extensive research.
- Healthcare Analysts: Utilize comprehensive data to assess market potential and company performance.
- Consultants: Tailor presentations and reports with up-to-date information on cutting-edge therapies.
- Biotech Enthusiasts: Explore the latest advancements in drug development and therapeutic strategies.
- Educators and Students: Leverage real-world case studies to enhance learning in biotechnology and finance.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Scopus BioPharma Inc. (SCPS) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), featuring parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models demonstrating intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Scopus BioPharma Inc. (SCPS).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to easily analyze results.